US Stock MarketDetailed Quotes

ALNY Alnylam Pharmaceuticals

Watchlist
  • 250.000
  • -6.450-2.52%
Close Feb 18 16:00 ET
  • 251.000
  • +1.000+0.40%
Post 17:21 ET
32.36BMarket Cap-114.68P/E (TTM)

Alnylam Pharmaceuticals Key Stats

Business Currency:USD
2024/FY
Stock NameRevenueRatio
AMVUTTRA970.45M43.16%
Net revenues from collaborations510.22M22.69%
GIVLAARI255.87M11.38%
ONPATTRO252.86M11.25%
OXLUMO167.05M7.43%
Royalty revenue91.79M4.08%
View all
Region Currency:USD
2024/FY
Stock NameRevenueRatio
United States933.54M41.52%
Europe516.3M22.96%
Net revenues from collaborations510.22M22.69%
Rest of world196.39M8.74%
Royalty revenue91.79M4.08%

Trending Stocks

Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Major earnings are approaching! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. 🎙️Discussion: 1 Show More